Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis

Authors:

Abstract
Background: Acute exacerbation of idiopathic pulmonary fibrosis (AE‐IPF) has an extremely poor prognosis. The role of ferritin in the pathogenesis of AE‐IPF is not well known while serum ferritin is a key prognostic indicator for patients with clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonia.Objective: To elucidate the clinical importance of serum ferritin in patients with AE‐IPF.Methods: Thirty‐seven patients (48 episodes), who were diagnosed with AE‐IPF and treated at our hospital between 1997 and 2015, were retrospectively studied.Results: Patients with AE‐IPF had significantly higher levels of serum ferritin than baseline levels at the first diagnosis of IPF (P = 0.0017). Receiver operating characteristic analysis showed the cut‐off value 174 ng/mL for the separation of AE (area under the curve, 0.700). No patients with AE‐IPF were positive for anti‐ melanoma differentiation‐associated gene 5 antibody. Patients with AE‐IPF and higher ferritin (≥174 ng/mL) had lower %FVC and %DLCO before AE, and those with much higher ferritin (≥500 ng/mL) had significantly worse prognosis than those with lower ferritin (log‐rank, P = 0.024). Immunohistochemical staining in autopsy specimens showed alveolar macrophages that were producing ferritin. Finally, in multivariate Cox proportional hazards analyses, serum ferritin level of ≥500 ng/mL was a significant worse prognostic factor (hazard ratio 5.280, P = 0.046).Conclusion: Higher serum ferritin may be related to a worse prognosis in patients with AE‐IPF.
Funding Information
  • Ministry of Health, Labour and Welfare

This publication has 28 references indexed in Scilit: